Provided by Tiger Trade Technology Pte. Ltd.

ImmunityBio, Inc.

10.29
+1.0110.83%
Post-market: 10.370.0850+0.83%16:48 EDT
Volume:31.11M
Turnover:318.24M
Market Cap:10.90B
PE:-10.40
High:10.55
Open:9.39
Low:9.39
Close:9.28
52wk High:12.43
52wk Low:1.95
Shares:1.06B
Float Shares:407.00M
Volume Ratio:2.42
T/O Rate:7.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9887
EPS(LYR):-0.3820
ROE:78.05%
ROA:-30.54%
PB:-10.41
PE(LYR):-26.92

Loading ...

Immunitybio Falls After Posting Q2 Loss

Reuters
·
Aug 04

Shares of Immunitybio Down 3.5% Premarket After Posting Q2 Loss

THOMSON REUTERS
·
Aug 04

Immunitybio Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Earnings Flash (IBRX) ImmunityBio Posts Q2 Net Loss $0.22 a Share, vs. FactSet Est of $0.08 Loss

MT Newswires Live
·
Aug 04

ImmunityBio Q2 Adj. EPS $(0.08) Beats $(0.09) Estimate, Sales $51.240M Beat $49.700M Estimate

Benzinga Earnings
·
Aug 04

ImmunityBio Q2 FY26 Net Loss Widens to $230.4 Million; Revenue Rises 92% YoY to $50.7 Million

Reuters
·
Aug 04

Immunitybio Q2 Revenue USD 51.24 Million VS. Ibes Estimate USD 49.7 Million

THOMSON REUTERS
·
Aug 04

Immunitybio Q2 EPS USD -0.22

THOMSON REUTERS
·
Aug 04

ImmunityBio Wins UAE Marketing Authorization for Anktiva in BCG-unresponsive Bladder Cancer

Reuters
·
Jul 30

Movement Alert|ImmunityBio, Inc. Declines 5.02% in Regular Trading, Trading at $7.675

Market Focus
·
Jul 23

Movement Alert|ImmunityBio Rises 5.34% in Regular Trading, Trading at $7.8601

Market Focus
·
Jul 21

Movement Alert|ImmunityBio Falls 5.11% in Regular Trading, Biotech Sector Profit-Taking Drives Continued Rotation Out of High-Beta Small Caps

Market Focus
·
Jul 17

Squeeze Watch: 10 Stocks Bears Love to Hate Most Right Now

Benzinga
·
Jul 14

Movement Alert|ImmunityBio Falls 5.17% in Regular Trading, Biotech Sector Profit-Taking Triggers Broad Pullback

Market Focus
·
Jul 14

Movement Alert|ImmunityBio Intraday Decline 5.58% in Regular Trading, Trading at $8.34

Market Focus
·
Jul 10

Movement Alert|ImmunityBio Falls 5.05% in Regular Trading, Trading at $8.475

Market Focus
·
Jul 07

Immunitybio Director Christobel Selecky Disposes of 159,478 Common Shares Worth $1.44 Million

Reuters
·
Jul 07

Movement Alert|ImmunityBio Falls 5.16% in Regular Trading, Trading at $8.685

Market Focus
·
Jul 06

Immunitybio Director Christobel Selecky Disposes of 96,722 Common Shares Worth $870,677.29

Reuters
·
Jul 02

Immunitybio Director Barry J. Simon Disposes of 25,000 Common Shares Worth $196,907.50

Reuters
·
Jun 27